Go online to PeerView.com/JAR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. While much of cancer therapy development focuses on systemic drugs and the mitigation of associated adverse events, new avenues utilizing innovative multimodal solutions have demonstrated the benefit of efficacy with minimal toxicity in solid tumors. New treatment modalities such as tumor treating fields (TTFields) and innovative combination strategies have emerged and entered into the management of solid tumors. This activity will feature a review of the cutting-edge advancements in cancer devices, as well as expert insights and case discussions on the appropriate care strategies for patients being treated with new modalities like TTFields therapy. And, the interdisciplinary panel of experts will review key safety and efficacy evidence on innovative and emerging multimodal strategies for the treatment of GBM, MPM, NSCLC, pancreatic cancer, and other GU and GI tumors. Upon completion of this activity, participants will be able to: Describe the mechanism of action and rationale for novel technologies, such as tumor treating fields (TTFields), as a cancer therapeutic strategy, Review key safety and efficacy evidence on innovative and emerging multimodal strategies for the treatment of GBM, MPM, and other solid tumors, Apply team-based strategies to minimize and manage the unique AEs associated with novel therapeutic platforms, such as TTFields therapy, for solid tumors, Provide guidance to patients on new cancer treatment modalities, such as TTFields therapy, to improve adherence and optimize cancer treatment outcomes.
View all episodes
